| Product NDC: | 21695-950 |
| Proprietary Name: | Metoprolol Succinate |
| Non Proprietary Name: | Metoprolol Succinate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Metoprolol Succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-950 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076862 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090803 |
| Package NDC: | 21695-950-30 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-950-30) |
| NDC Code | 21695-950-30 |
| Proprietary Name | Metoprolol Succinate |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-950-30) |
| Product NDC | 21695-950 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metoprolol Succinate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090803 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | METOPROLOL SUCCINATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |